Cargando…

A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations

RATIONALE: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by abnormal vessel growth that results in telangiectasias and arteriovenous malformations (AVMs) in the skin, mucosa, and viscera. Up to 30% of patients with HHT exhibit pulmonary AVMs (PAVMs), cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnan, Sheila, Lahm, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133419/ https://www.ncbi.nlm.nih.gov/pubmed/30095617 http://dx.doi.org/10.1097/MD.0000000000011513

Ejemplares similares

Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence
por: de Gussem, Els M., et al.
Publicado: (2020)

Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence
por: Kilian, Alexandra, et al.
Publicado: (2020)

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017)

Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients
por: Guilhem, Alexandre, et al.
Publicado: (2017)

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019)

Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation
por: Joyce, Katie E., et al.
Publicado: (2022)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT
por: Le, Thi Thao Truc, et al.
Publicado: (2022)

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
por: Shovlin, Claire L., et al.
Publicado: (2018)

Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial
por: Mei-Zahav, Meir, et al.
Publicado: (2020)

Endoglin involvement in integrin-mediated cell adhesion as a putative pathogenic mechanism in hereditary hemorrhagic telangiectasia type 1 (HHT1)
por: Rossi, Elisa, et al.
Publicado: (2015)

Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14
por: Letteboer, Tom G. W., et al.
Publicado: (2015)

Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations()
por: Girit, Saniye, et al.
Publicado: (2020)

Time heals all wounds—but 12-HHT is faster
por: Gus-Brautbar, Yael, et al.
Publicado: (2014)

Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT
por: Kilian, Alexandra, et al.
Publicado: (2023)

Mononuclear cells and vascular repair in HHT
por: Dingenouts, Calinda K. E., et al.
Publicado: (2015)

Genotype–Phenotype Correlations in Children with HHT
por: Kilian, Alexandra, et al.
Publicado: (2020)

TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial
por: Andorfer, Kornelia E. C., et al.
Publicado: (2022)

European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)
por: Eker, Omer F., et al.
Publicado: (2020)

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021)

Embolotherapy for Pulmonary Arteriovenous Malformations in Patients without Hereditary Hemorrhagic Telangiectasia
por: Shin, Ji Hoon, et al.
Publicado: (2010)

Pulmonary Arteriovenous Malformation in a Rare Case of Hereditary Hemorrhagic Telangiectasia
por: Azad, Farhan, et al.
Publicado: (2022)

Clinical and genetic challenges in a family with history of childhood polyp, aortopathy, and clinical diagnosis of hereditary hemorrhagic teleangiectasia (HHT)
por: Kadiyska, Tanya, et al.
Publicado: (2016)

Classification of endonasal HHT lesions using digital microscopy
por: Haubner, F., et al.
Publicado: (2021)

Incidence of Spontaneous Pulmonary AVM Rupture in HHT Patients
por: Fish, Adam, et al.
Publicado: (2021)

Improved HHT-microstate analysis of EEG in nicotine addicts
por: Xiong, Xin, et al.
Publicado: (2023)

Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes
por: Govani, Fatima S, et al.
Publicado: (2010)

Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study
por: Mowers, Katie L., et al.
Publicado: (2018)

Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations
por: de Picciotto, Carole, et al.
Publicado: (2019)

Individualized therapy of HHT driven by network analysis of metabolomic profiles
por: Jamshidi, Neema, et al.
Publicado: (2011)

Early detection of myocardial ischemia in resting ECG: analysis by HHT
por: Wang, Chun-Lin, et al.
Publicado: (2023)

Executive summary of the 14th HHT international scientific conference
por: Ola, Roxana, et al.
Publicado: (2023)

Novel Brain Arteriovenous Malformation Mouse Models for Type 1 Hereditary Hemorrhagic Telangiectasia
por: Choi, Eun-Jung, et al.
Publicado: (2014)

Pulmonary Arteriovenous Malformation and Embolic Myocardial Infarction in a Patient With Hereditary Hemorrhagic Telangiectasia
por: Sánchez-Fernández, Gabriel, et al.
Publicado: (2020)

Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
por: Cusumano, Lucas R., et al.
Publicado: (2021)

Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: Recent advances in cellular and molecular mechanisms
por: Drapé, Elise, et al.
Publicado: (2022)

HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis
por: Lux, Andreas, et al.
Publicado: (2013)

Long-term efficacy assessment of current treatment options for epistaxis in HHT
por: Dür, Cilgia, et al.
Publicado: (2021)

Hereditary Hemorrhagic Telangiectasia with Hepatic Vascular Malformations
por: Nishioka, Yujiro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_adb8nqmadg8fb7459dgl8agj9e